Loss Aversion and Cost Effectiveness of Healthcare Programmes Afschin Gandjour Commentary 17 September 2012 Pages: 895 - 898
Loss Aversion and Cost Effectiveness of Healthcare Programmes Johan L. Severens Commentary 17 September 2012 Pages: 899 - 900
Methods for the Meta-Analysis of Willingness-to-Pay Data George Van Houtven Leading Article 17 September 2012 Pages: 901 - 910
The Impact of Influenza on Working Days Lost Martin KeechPaul Beardsworth Review Article 17 September 2012 Pages: 911 - 924
A Review of Health-Utility Data for Osteoarthritis Hirsch S. RuchlinRalph P. Insinga Review Article 17 September 2012 Pages: 925 - 935
A Cost-Effectiveness Analysis of Currently Approved Treatments for HBeAg-Positive Chronic Hepatitis B D. Eldon SpackmanDavid L. Veenstra Original Research Article 17 September 2012 Pages: 937 - 949
Economic Impact and Long-Term Graft Outcomes of Mycophenolate Mofetil Dosage Modifications Following Gastrointestinal Complications in Renal Transplant Recipients Gerardo MachnickiJean-Francois RicciMark A. Schnitzler Original Research Article 17 September 2012 Pages: 951 - 967
Escitalopram and Duloxetine in Major Depressive Disorder Alan G. WadeJosé-Luis FernándezNicolas Despiege Original Research Article 17 September 2012 Pages: 969 - 981